News

• Science & Technology
• Health & Medicine

NICE recommends elranatamab for adults with a rare form of blood cancer

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

1 November 2024

• Policy & Insight
• Health & Medicine

Around 350 young adults start smoking every day in the UK

New research that we funded has revealed that more than 127,000 18–25-year-olds start smoking tobacco regularly each year in the UK – that's around 350 per day. New research that we funded has revealed that more than 127,000 18–25-year-olds start smoking tobacco regularly each year in the UK – that's around 350 per day.

25 October 2024

• Science & Technology
• Charity News

£3m for world-first trial to revolutionise brain cancer treatment

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

23 October 2024

• Science & Technology

Selenium: Could a common mineral help prevent the spread of cancer?

Limiting breast cancer cells’ ability to consume selenium, an essential mineral found in Brazil nuts, could be a way to stop them spreading. Limiting breast cancer cells’ ability to consume selenium, an essential mineral found in Brazil nuts, could be a way to stop them spreading.

22 October 2024

• Policy & Insight

Cancer Research UK joins leading organisations in calling for Government to back R&D

We've joined the Campaign for Science and Engineering (CaSE), and others in the R&D sector, in writing to the Chancellor urging the UK Government to back R&D if it wants to achieve its ambitions for economic and social growth.  We've joined the Campaign for Science and Engineering (CaSE), and others in the R&D sector, in writing to the Chancellor urging the UK Government to back R&D if it wants to achieve its ambitions for economic and social growth. 

18 October 2024

• Charity News

Cancer Research UK makes unprecedented £173m commitment to world-class research in Cambridge

We’re excited to announce a £173m investment in our Cambridge Institute – the largest single grant we have ever awarded outside of London.   We’re excited to announce a £173m investment in our Cambridge Institute – the largest single grant we have ever awarded outside of London.  

15 October 2024

• Science & Technology

New hand-held scanner could transform cancer and arthritis diagnosis

A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time. A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time.

15 October 2024

• Health & Medicine

Next-gen personalised radiotherapy could cure more bladder cancers and cut side effects

A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies.  A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies. 

7 October 2024

• Charity News

£600,000 given to create the world’s first ovarian cancer prevention vaccine

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

4 October 2024

• Science & Technology
• Health & Medicine

Introducing DIY steps to genetic testing could catch more BRCA-linked cancer cases

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

1 October 2024

• Charity News

We’re accelerating brain tumour research with £8m more for our Brain Tumour Centres of Excellence

Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments. Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments.

24 September 2024

• Health & Medicine

300,000 won’t start cancer treatment on time if waiting times don't improve

With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance.  With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance. 

20 September 2024